CJUR-STK328
Sub-Total :
$ 0
Customize Product Request Quote
Contact Us
Contact Us
Sub-Total:
$ 0
  • Performance Data
  • Reviews & Citations
  • Important Statement
  • Resources
    1. Genetically modified cell lines best reflect MOA (Mechanism of Action)
    2. Higher activity and larger assay window for robust and reproducible cell-based bioassay
    3. Comprehensive application data to support assay development and validation
    4. Full tracible record, stringent quality control and validated cell passage stability
    5. Parental cell line legally obtained from internationally recognized cell resource bank and commercially licensed
    6. Global commercial license assistance whenever regulatory filing is required
  • Description

    The Jurkat/Human CD5 Knockout Stable Cell Line was generated from Jurkat cells through targeted knockout of human CD5 (Gene ID: 921). The expression level of human CD5 was confirmed by flow cytometry. Mutated sequences of human CD5 produced by non-homologous end joining (NHEJ) were confirmed through genomic sequencing.

  • Application

    • Useful for cell-based CD5 target-specific analysis

  • Growth Properties

    Suspension

  • Selection Marker

    NA

  • Complete Growth Medium

    RPMI 1640 + 10% FBS

  • Freeze Medium

    Serum-free cell cryopreservation medium

  • Quantity

    1 vial contains at least 5×10^6 cells in 1 mL serum-free cryopreservation medium

  • Storage

    Frozen in liquid nitrogen.

  • Mycoplasma Testing

    Negative

  • Sterility Testing

    Negative

  • Instructions for Use

    See data sheet for detailed culturing and assay protocol.

  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process